BioSpace News Archive

Deals

Brain Scientific Commences Trading on OTCQB Venture Market

via NEWMEDIAWIRE – Brain Scientific Inc., a neurology-focused medical device and software company, announced that its common stock commenced trading as of July 29, 2020 on the OTCQB® Venture Market.

August 3, 2020
·
3 min read
Bio NC

RedHill Biopharma Announces New Agreement with Daiichi Sankyo for Movantik®

RedHill acquired Movantik® for opioid induced constipation from AstraZeneca in April 2020; Movantik® generated $96 million in 2019

August 3, 2020
·
10 min read
Policy

HOOKIPA Announces Issuance of US and European Patents

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers, announced that both the United States Patent and Trademark Office and the European Patent Office have issued patents covering HOOKIPA’s proprietary replicating arenavirus technology.

August 3, 2020
·
6 min read
Deals

Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million

Tiziana Life Sciences plc, announced it has entered into definitive agreements with investors for the purchase and sale of 11,009,615 of the Company’s American Depositary Shares at a price of $5.20 per ADS pursuant to a registered direct offering.

August 3, 2020
·
10 min read
Policy

IRLAB’s IRL752 is proposed pirepemat as a unique INN by WHO

IRLAB announced that the World Health Organization has proposed the name pirepemat as the International Nonproprietary Name for the company’s drug candidate IRL752, which is in development for decreasing the risk of falling in patients with Parkinson’s disease.

August 3, 2020
·
1 min read
BioMidwest

Exact Sciences to participate in August 2020 investor conference

Exact Sciences Corp. announced that company management will participate in the following conference and invited investors to participate by webcast.

August 3, 2020
·
5 min read
Business

Precision BioSciences to Report Second Quarter 2020 Financial Results and Present at Upcoming Investor Conferences

Precision BioSciences, Inc., a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform announced it will report financial results for the second quarter of 2020 on August 13, 2020.

August 3, 2020
·
1 min read
Gout Therapeutics Market - High Growth Potential of Biologics and Preference of Combination Therapies Drive Market Growth

The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain.

August 3, 2020
·
5 min read
Business

ASLAN Pharmaceuticals Appoints Kenneth Kobayashi, MD, as Chief Medical Officer

ASLAN Pharmaceuticals, a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced that Dr Kenneth Kobayashi has been appointed Chief Medical Officer.

August 3, 2020
·
5 min read
Business

MEDICREA Announces the Appointment of an Independent Expert

The MEDICREA® Group, pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI proprietary software platform, services and technologies, announces the appointment of an independent expert.

August 3, 2020
·
3 min read